During the past decade, AOU Policlinico "Mater Domini" UOC di Medicina interna conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AOU Policlinico "Mater Domini" UOC di Medicina interna" are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "AOU Policlinico "Mater Domini" UOC di Medicina interna" in a lesser frequency.

Most popular intervention types in "AOU Policlinico "Mater Domini" UOC di Medicina interna" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "AOU Policlinico "Mater Domini" UOC di Medicina interna" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AOU Policlinico "Mater Domini" UOC di Medicina interna". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in AOU Policlinico "Mater Domini" UOC di Medicina interna, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in AOU Policlinico "Mater Domini" UOC di Medicina interna, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".